15 results · 26ms · Sources: EU EUDAMED, US FDA

Get notified when this changes

We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

Mould Probe MR Safe

FDA 510(k)
FDA Class 2 ·Radiology

TRISTAR BONE GRAFT FIXATION SYSTEM

FDA 510(k)
FDA Class 2 ·Dental

THE VITROS 5,1 FS CHEMISTRY SYSTEM

FDA 510(k)
FDA Class 2 ·Hematology

VERSACEM ACETABULAR SHELL AND DOUBLE MOBILITY HC LINERS

FDA Adverse Event
Injury ·MEDACTA INTERNATIONAL SA·Product code LZO·October 8, 2025

DOUBLE MOBILITY LINER

FDA Adverse Event
Injury ·MEDACTA INTERNATIONAL SA·Product code MEH·April 30, 2026

SECURE II MED/SURG BED

FDA Adverse Event
Injury ·STRYKER CORP., MEDICAL DIVISION·Product code FNL·November 19, 2008

COLLEAGUE

FDA Adverse Event
Malfunction ·BAXTER HEALTHCARE - SINGAPORE·Product code FRN·September 9, 2011

ASR ACETABULAR CUPS 56

FDA Adverse Event
Injury ·DEPUY INTL., LTD. - 8010379·Product code KWA·July 22, 2013

VERSACEM ACETABULAR SHELL AND DOUBLE MOBILITY HC LINERS

FDA Adverse Event
Injury ·MEDACTA INTERNATIONAL SA·Product code LZO·May 5, 2026

MECTACER BIOLOX DELTA FEMORAL BALL HEAD

FDA Adverse Event
Injury ·MEDACTA INTERNATIONAL SA·Product code LZO·November 18, 2025

AMISTEM-P COLLARED

FDA Adverse Event
Injury ·MEDACTA INTERNATIONAL SA·Product code LPH·October 29, 2025

DM CONVERTER ¿ TIN COATED

FDA Adverse Event
Injury ·MEDACTA INTERNATIONAL SA·Product code LZO·March 31, 2026

MECTACER BIOLOX OPTION HEADS

FDA Adverse Event
Injury ·MEDACTA INTERNATIONAL SA·Product code LZO·October 7, 2025

VERSACEM ACETABULAR SHELL AND DOUBLE MOBILITY HC LINERS

FDA Adverse Event
Injury ·MEDACTA INTERNATIONAL SA·Product code LZO·March 30, 2026

Boston Scientific TELIGEN, Implantable Cardiac Defibrillator models E102, E110, the following models are not available in the US: models E103, E111, F102, F103, F110, F111. Sterilized using ethylene oxide. Product Usage: This family of implantable cardioverter defibrillators (ICDs) provide a variety of therapies including: -Ventricular tachyarrhythmia therapy, which is used to treat rhythms associated with sudden cardiac death such as VT and VF; -Bradycardia pacing, including adaptive rate pacing, to detect and treat bradyarrhythmias and to provide cardiac rate support after defibrillation therapy. Boston Scientific implantable cardioverter defibrillators (ICDs) are indicated to provide ventricular antitachycardia pacing (ATP) and ventricular defibrillation for automated treatment of life-threatening ventricular arrhythmias

FDA Enforcement
Class II ·Terminated·Boston Scientific CRM Corp·October 29, 2014